Top news of the week: 22.04.2021.
Healthcare
Clive Dix: Rebuilding UK biotech
UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last 12 months, as CEO of C4X Discovery and as head of the UK vaccines taskforce.
BioSpace Movers & Shakers, April 16
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Single-cell multi-omics analysis of the immune response in COVID-19
Transcriptomic and proteomic profiling of blood samples from individuals with COVID-19 reveals immune cell and hematopoietic progenitor cell alterations that are differentially associated ...
4SC provides Q1 2021 update
Financially, the Company is also in a good position having sold our remaining royalty rights back to Immunic, generating significant additional non-dilutive financing, which …
Atriva Therapeutics to Speed up Development of COVID-19 Drug with Federal Funding
First-in-class inhibitors against seasonal and pademic influenza
JLABS @ Toronto: Not by Chance—By Choice.
Maintain complete control of your intellectual property Introduce innovators to vital industry connections Provide direct pathway to early stage science investors Mentors and …
Medical Information and Communications Conference
Medical Information and Communications Conference
Gene Machine
Jonathan Rothberg's desktop decoder could kick off a revolution in medicine, food, energy, even consumer products--and ignite the next $100 billion technology market.